Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Novo Nordisk stock fell after the drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its ...

Doctors are seeing an increase in hair loss among Ozempic users due to the stress of rapid weight loss. The condition is ...

About 2% of U.S. adults use GLP-1 drugs, but results vary. Diet, exercise, and mental health remain key to long-term success.

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Learn whether you can experience heartburn during treatment with Ozempic and how you might prevent or treat it.